⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28857285 | 1.00 | — | — | |
| SCHEMBL294887 | 0.93 | ALOX15 (0.52) | — | |
| SCHEMBL2368497 | 0.91 | ALOX15 (0.50) | — | |
| SCHEMBL9306274 | 0.91 | ALOX15 (0.50) | — | |
| SCHEMBL4591909 | 0.91 | ALOX15 (0.50) | — | |
| SCHEMBL4428879 | 0.91 | ALOX15 (0.50) | — | |
| SCHEMBL5872624 | 0.84 | ALOX15 (0.38) | — | |
| SCHEMBL7095968 | 0.84 | — | — | |
| SCHEMBL12837120 | 0.84 | — | — | |
| SCHEMBL5872626 | 0.84 | ALOX15 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115160202-B | Preparation method of carboprost tromethamine and intermediate thereof | 广州楷石医药有限公司 | 2023-10-31 | — | — | CN | claimed |
| CN-115160202-A | Preparation method of carboprost tromethamine and intermediate thereof | 广州楷石医药有限公司 | 2022-10-11 | — | — | CN | claimed |
| CN-118577268-A | Preparation method of supported conformal nano metal catalyst, product and application thereof | 浙江大学 | 2024-09-03 | — | — | CN | disclosed |
| CN-115160202-B | Preparation method of carboprost tromethamine and intermediate thereof | 广州楷石医药有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-115160202-A | Preparation method of carboprost tromethamine and intermediate thereof | 广州楷石医药有限公司 | 2022-10-11 | — | — | CN | disclosed |
| EP-3231789-A1 | BIOMARKERS FOR DIAGNOSING MULTIPLE SCLEROSIS, AND METHODS THEREOF | Phenomenome Discoveries Inc. (CA) | 2017-10-18 | — | — | EP | disclosed |
| EP-2682746-B1 | Methods for the diagnosis of ovarian cancer health states and risk of ovarian cancer health states | PHENOMENOME DISCOVERIES INC (CA) | 2017-05-24 | — | — | EP | disclosed |
| US-20160377623-A1 | METHODS FOR THE DIAGNOSIS OF OVARIAN CANCER HEALTH STATES AND RISK OF OVARIAN CANCER HEALTH STATES | MED-LIFE DISCOVERIES LP (CA) | 2016-12-29 | — | — | US | disclosed |
| US-20160305928-A1 | METHODS FOR THE DIAGNOSIS OF OVARIAN CANCER HEALTH STATES AND RISK OF OVARIAN CANCER HEALTH STATES | MED-LIFE DISCOVERIES LP (CA) | 2016-10-20 | — | — | US | disclosed |
| US-20160305928-A1 | METHODS FOR THE DIAGNOSIS OF OVARIAN CANCER HEALTH STATES AND RISK OF OVARIAN CANCER HEALTH STATES | MED-LIFE DISCOVERIES LP (CA) | 2016-10-20 | — | — | US | disclosed |
| EP-2644588-A2 | Biomarkers for diagnosing multiple sclerosis, and methods thereof | Phenomenome Discoveries Inc. (CA) | 2013-10-02 | — | — | EP | disclosed |
| US-20100086960-A1 | METHODS FOR THE DIAGNOSIS OF OVARIAN CANCER HEALTH STATES AND RISK OF OVARIAN CANCER HEALTH STATES | PHENOMENOME DISCOVERIES INC. (CA) | 2010-04-08 | — | — | US | disclosed |
| US-20100086960-A1 | METHODS FOR THE DIAGNOSIS OF OVARIAN CANCER HEALTH STATES AND RISK OF OVARIAN CANCER HEALTH STATES | PHENOMENOME DISCOVERIES INC. (CA) | 2010-04-08 | — | — | US | disclosed |
| US-20100062472-A1 | BIOMARKERS FOR DIAGNOSING MULTIPLE SCLEROSIS, AND METHODS THEREOF | PHENOMENOME DISCOVERIES INC. (CA) | 2010-03-11 | — | — | US | disclosed |
| US-20100062472-A1 | BIOMARKERS FOR DIAGNOSING MULTIPLE SCLEROSIS, AND METHODS THEREOF | PHENOMENOME DISCOVERIES INC. (CA) | 2010-03-11 | — | — | US | disclosed |